Search bioRxiv⌕ Search

Biology subjects

Teubner, B. J. W.

Publications and source records attributed to Teubner, B. J. W..

2 recordsLinked to original sources

LRRC57/RABIN is a presynaptic inhibitor of Rab GTPases in glutamatergic neurons

Synaptic vesicle cycling, if not properly constrained, can result in excessive neurotransmitter release and subsequent neural pathology. Rab GTPases orchestrate synaptic vesicle trafficking through GTP-dependent interactions with effector proteins, but the restraining mechanism of these interactions is unknown. Here we identify LRRC57 (or RABIN for RAB INhibitor), a conserved brain-enriched protein in glutamatergic synapses that binds multiple GTP-loaded synaptic Rabs and competitively blocks access to their effectors. Loss of Rabin increased glutamate release, expanded vesicle pools, accelerated vesicle turnover, and produced circuit hyperexcitability with epileptiform activity, which was mitigated by an antiepileptic agent that targets presynaptic function. Conversely, overexpression of the Rabin gene suppressed neurotransmitter release and protected against induced seizures and persistent epileptiform discharges. Together, these findings define a noncanonical decoy-effector mechanism that constrains presynaptic Rab signaling to preserve excitatory circuit stability.

neuroscience↗

Schizophrenia-associated 22q11.2 deletion elevates striatal acetylcholine and disrupts thalamostriatal projections to produce amotivation in mice

Schizophrenia is a complex neurodevelopmental disorder characterized by cognitive dysfunction, hallucinations, and negative symptoms such as amotivation. Negative symptoms are largely resistant to current antipsychotic treatments, and the neural circuits underlying amotivational states remain poorly defined. Here, using a mouse model of schizophrenia-associated 22q11.2 deletion syndrome (22q11DS), we report amotivation and weakened glutamatergic synaptic transmission between the thalamic parafascicular nucleus (Pf) and the dorsomedial striatum (DMS). Thalamostriatal disruption is attributed to hyperactivity of striatal cholinergic interneurons (CHIs), which is associated with enhanced Trpc3 and Pex51 (Trip8b) gene expression. Elevated acetylcholine levels in the DMS act on presynaptic M2 muscarinic receptors to weaken Pf-DMS glutamatergic transmission. Importantly, disruption of Pf-DMS synaptic transmission or hyperactivation of CHIs are each sufficient to cause amotivation in wild-type mice. These results identify a striatal hypercholinergic state and subsequent thalamostriatal disruption as core pathogenic events causing amotivation in 22q11DS, providing potential therapeutic targets.

neuroscience↗